首页> 外文会议>International Joint Conference on Computer Science and Software Engineering >Detection of Drug-Associated Rhabdomyolysis Through Data Mining Techniques
【24h】

Detection of Drug-Associated Rhabdomyolysis Through Data Mining Techniques

机译:通过数据挖掘技术检测药物相关的横纹肌溶解

获取原文

摘要

Rhabdomyolysis (RM) is a life-threatening adverse drug reaction (ADR). Statins are the common drugs causing RM and weakness as well as a combination with other drugs, which increase the level of statins. The estimated cost per QALY of supportive treatment for RM was 69,742.50 USD per year, but the early detection of ADRs can reduce the cost of approximately 1,400.00 USD per patient. RM has a problem of under-reporting in spontaneous reporting systems (SRSs). Detecting RM at the early stage is the crucial task by finding the relationship between drugs and RM from electronic health records (EHRs). The aim of this study is to propose a predictive model for RM analysis by predicting the probability of RM or weakness in patients who used statin alone or combined with other drugs. The proposed model can predict the probability occurrence of RM or weakness with sensitivity equal to 0.66.
机译:横纹肌分解(RM)是威胁危及生命的不良药物反应(ADR)。他汀类药物是常见的药物,导致RM和弱点以及与其他药物的组合增加,这增加了他汀类药物的水平。每年QALY的估计成本为RM为每年69,742.50美元,但ADR的早期检测可降低每位患者约1,400.00美元的成本。 RM在自发报告系统(SRSS)中存在报告后的问题。在早期阶段检测RM是通过从电子健康记录(EHRS)之间的药物和RM之间的关系来检测至关重要的任务。本研究的目的是通过预测使用单独使用他汀类药物或与其他药物结合使用的患者的RM或弱度的概率来提出RM分析的预测模型。所提出的模型可以预测具有等于0.66的灵敏度的RM或弱度的概率发生。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号